Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia

Journal of Postgraduate Medicine

Volumn 52, Issue 1, 2006, Pages 23-29

  Raja, N S ^a   Parasakthi, N ^a   Puthucheary, S D ^a   Kamarulzaman, A ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Bacterial meningitis; Meningococcal meningitis; Neisseria meningitidis

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; MENINGOCOCCUS VACCINE; PENICILLIN G; RIFAMPICIN;

ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FEVER; HEADACHE; HEARING LOSS; HUMAN; MALAYSIA; MALE; MENINGOCOCCOSIS; MUSCLE STIFFNESS; NECK MUSCLE; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; UPPER RESPIRATORY TRACT; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALAYSIA; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; TREATMENT OUTCOME;

EID: 33645002964     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000;13:144-66.
2. Fonkoua MC, Taha MK, Nicolas P, Cunin P, Alonso JM, Bercion R, et al. Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon. Emerg Infect Dis 2002;8:327-9.
3. World Health Organisation; Regional office for South East Asia. Communicable Diseases Department Report. Meningococcal disease in Delhi. http:// w3.whosea.org/EN/Section10/Section1973.htm
4. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000;356:2159.
5. Issack MI, Ragavoodoo C. Hajj-related Neisseria meningitidis serogroup W135 in Mauritius. Emerg Infect Dis 2002;8:332-4.
6. Wilder-Smith A, Goh KT, Barkham T, Paton NI. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135:estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 2003;36:679-83.
7. Perkins BA. New opportunities for prevention of meningococcal disease. JAMA 2000;283:2842-3.
8. Racoosin JA, Whitney CG, Conover CS, Diaz PS. Serogroup Y meningococcal disease in Chicago, 1991-1997. JAMA 1998;280:2094-8.
9. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999;180:1894-901.
10. Glennie L. Meningitis:a rash diagnosis. Nurs Times 2000;96:44-5.
11. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344:1378-88.
12. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
13. British Society of Antimicrobial Chemotherapy. Guide to Antimicrobial Susceptibility Testing document Version 2 - July 2001. http://www.bsac.org.uk/ susceptibility_testing/bsac_standardized_disc_susceptibility_method.cfm
14. Puthucheary SD, Parasakthi N, Liew ST. Rapid diagnosis of acute bacterial meningitis by coagglutination and latex agglutination. Serodiagnosis and Immunotherapy in Infectious Diseases 1989;3:317-21.
15. Schwartz B. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections. Rev Infect Dis 1991;13:S170-3.
16. De Wals P, Hertoghe L, Borlee-Grimee I, De Maeyer-Cleempoel S, Reginster-Haneuse G, Dachy A et al. Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect 1981;3:53-61.
17. Stuart JM, Cartwright KA, Dawson JA, Rickard J, Noah ND. Risk factors for meningococcal diseases:a case control study in southwest England. Commun Med 1988;10:139-46.
18. Moore PS, Hierholzer J, DeWitt W, Gouan K, Djore D, Lippeveld T, et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 1990;264:1271-5.
19. Chan YC, Wilder-Smith A, Ong BK, Kumarasinghe G, Wilder-Smith E. Adult community acquired bacterial meningitis in a Singaporean teaching hospital. A seven-year overview (1993-2000). Singapore Med J 2002;43:632-6.
20. Wilson DC, Crean PM, Jenkins JG. Adult respiratory distress syndrome (ARDS) complicating meningococcaemia. Ir J Med Sci 1991;160:10-1.
21. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1993;12:389-94.
22. Hall RG. The control of meningococcal disease. Med J Aust 2002;176:573-4.
23. Cartwright K, Kroll S. Optimising the investigation of meningococcal disease. BMJ 1997;315:757-8.
24. van Deuren M, van Dijke BJ, Koopman RJ, Horrevorts AM, Meis JF, Santman FW, et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 1993;306:1229-32.
25. de Gans J, van de Beek D. European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-56.
26. Dull PM, Abdelwahab J, Sacchi CT, Becker M, Noble CA, Barnett GA, et al. Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj. J Infect Dis 2005;191:33-9.